Literature DB >> 3954803

Phagocytosis and intracellular killing of Staphylococcus aureus by polymorphonuclear cells from synovial fluid of patients with rheumatoid arthritis.

F C Breedveld, G J Lafeber, M T van den Barselaar, J T van Dissel, P C Leijh.   

Abstract

The phagocytosis and intracellular killing by synovial fluid (SF) polymorphonuclear cells (PMN) of 10 patients with rheumatoid arthritis was studied. PMN phagocytosis was assessed by morphologic and microbiologic methods and intracellular killing was measured independently of continuous phagocytosis of Staphylococcus aureus. Phagocytosis of S aureus by SF PMN or peripheral blood (PB) PMN was as effective in the presence of synovial fluid as in the presence of serum. On average, SF PMN ingested S aureus opsonized with synovial fluid and serum more efficiently than patient or donor PB PMN did. Enhanced ingestion of S aureus was associated with increased expression of C3 receptors on the membrane of SF PMN. In the presence of heat-inactivated synovial fluid, the capacity of SF PMN to ingest S aureus was greater than that of patient or donor PB PMN. Under these conditions, phagocytic activity was correlated with Fc receptor expression. SF PMN was found to be as active in killing S aureus as PB PMN from healthy donors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954803     DOI: 10.1002/art.1780290203

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

1.  Activation of the neutrophil myeloperoxidase-H2O2 system by synovial fluid isolated from patients with rheumatoid arthritis.

Authors:  H L Nurcombe; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1991-04       Impact factor: 19.103

2.  Neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis: priming and activation in vivo.

Authors:  H L Nurcombe; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

3.  Activation of neutrophils by soluble and insoluble immunoglobulin aggregates from synovial fluid of patients with rheumatoid arthritis.

Authors:  J J Robinson; F Watson; M Phelan; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

4.  Activation of neutrophil reactive-oxidant production by synovial fluid from patients with inflammatory joint disease. Soluble and insoluble immunoglobulin aggregates activate different pathways in primed and unprimed cells.

Authors:  J Robinson; F Watson; R C Bucknall; S W Edwards
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

5.  Synovial fluid neutrophils of patients with rheumatoid arthritis have membrane antigen changes that reflect activation.

Authors:  P Emery; A F Lopez; G F Burns; M A Vadas
Journal:  Ann Rheum Dis       Date:  1988-01       Impact factor: 19.103

Review 6.  A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis.

Authors:  A A Kalla; A F Tooke; E Bhettay; O L Meyers
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

7.  Septic arthritis in patients with rheumatoid arthritis.

Authors:  Abdulaziz Al-Ahaideb
Journal:  J Orthop Surg Res       Date:  2008-07-29       Impact factor: 2.359

8.  Simultaneous bilateral septic arthritis of the knee after intraarticular steroid injection: A clinical report.

Authors:  Sudarshan Munigangaiah; Theresa A O'Sullivan; Brian Lenehan
Journal:  J Nat Sci Biol Med       Date:  2014-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.